0Suppliers
4Customers
1Debt Items
0Related Chains

ImmuCell Corporation Suppliers

No suppliers on recordImmuCell Corporation has not yet been matched to upstream suppliers in our database, or is still being processed.

ImmuCell Corporation Customers

TickerNameConfidenceEvidence
COMPANY-A COMPANY-A 95% Sales to significant customers that amounted to 10 percent or more of total product sales are detailed in the following table: Three Months Ended March 31, 2026 2025 Company A 35 % 44 %
COMPANY-B COMPANY-B 92% Sales to significant customers that amounted to 10 percent or more of total product sales are detailed in the following table: Three Months Ended March 31, 2026 2025 Company B 25 % 27 %
COMPANY-C COMPANY-C 92% Sales to significant customers that amounted to 10 percent or more of total product sales are detailed in the following table: Three Months Ended March 31, 2026 2025 Company C * 10 %
NORBROOK-LABORATORIES-LIMITED NORBROOK-LABORATORIES-LIMITED 90% Under the Settlement Deed, Norbrook has agreed to pay ImmuCell the sum of $2,000,000.

ImmuCell Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
ICCC-DEBT Debt stack $12.8M 90% Market cache reports total debt of $12.8M.

ImmuCell Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ImmuCell Corporation.

ImmuCell Corporation Ownership

HolderNameConfidenceEvidence
ICCC-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 28 tracked holders.

ImmuCell Corporation Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.